WGS
GeneDx Holdings Corp.
NASDAQ: WGS · HEALTHCARE · DIAGNOSTICS & RESEARCH
$39.61
-7.22% today
Updated 2026-06-05
Market cap
$1.78B
P/E ratio
—
P/S ratio
4.02x
EPS (TTM)
$-2.66
Dividend yield
—
52W range
$32 – $171
Volume
1.4M
GeneDx Holdings Corp. (WGS) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$39.61
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.2B | $0.2B | $0.2B | $0.3B | $0.4B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -17.60%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.